Priming of beta-2 agonist and antimuscarinic induced physiological responses induced by 1200mg/day NAC in moderate to severe COPD patients: A pilot study
• We investigated effects of antioxidant on bronchodilator-response in COPD patients. • Antioxidant-therapy modulates antimuscarinic lung-hyperinflation responses. • No beta-2 agonist lung-physiology response was modulated by antioxidant-therapy.
Gespeichert in:
| Autor*in: |
Sinojia, Ravikumar [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2014 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
8 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Usage of formal financial services in India: Demand barriers or supply constraints? - Kumar, Abhishek ELSEVIER, 2018, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:191 ; year:2014 ; day:15 ; month:01 ; pages:52-59 ; extent:8 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.resp.2013.10.010 |
|---|
| Katalog-ID: |
ELV017396492 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV017396492 | ||
| 003 | DE-627 | ||
| 005 | 20230623134621.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180602s2014 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.resp.2013.10.010 |2 doi | |
| 028 | 5 | 2 | |a GBVA2014007000004.pica |
| 035 | |a (DE-627)ELV017396492 | ||
| 035 | |a (ELSEVIER)S1569-9048(13)00347-9 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 330 |q VZ |
| 100 | 1 | |a Sinojia, Ravikumar |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Priming of beta-2 agonist and antimuscarinic induced physiological responses induced by 1200mg/day NAC in moderate to severe COPD patients: A pilot study |
| 264 | 1 | |c 2014 | |
| 300 | |a 8 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a • We investigated effects of antioxidant on bronchodilator-response in COPD patients. • Antioxidant-therapy modulates antimuscarinic lung-hyperinflation responses. • No beta-2 agonist lung-physiology response was modulated by antioxidant-therapy. | ||
| 650 | 7 | |a Ipratropium-bromide |2 Elsevier | |
| 650 | 7 | |a Anti-oxidant |2 Elsevier | |
| 650 | 7 | |a n-acetyl-cysteine |2 Elsevier | |
| 650 | 7 | |a Priming |2 Elsevier | |
| 650 | 7 | |a Salbutamol |2 Elsevier | |
| 700 | 1 | |a Shaikh, Moin |4 oth | |
| 700 | 1 | |a Kodgule, Rahul |4 oth | |
| 700 | 1 | |a Bhosale, Satish |4 oth | |
| 700 | 1 | |a Madas, Sapna |4 oth | |
| 700 | 1 | |a Vaidya, Abhijit |4 oth | |
| 700 | 1 | |a Salvi, Sundeep |4 oth | |
| 700 | 1 | |a Brashier, Bill |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier Science |a Kumar, Abhishek ELSEVIER |t Usage of formal financial services in India: Demand barriers or supply constraints? |d 2018 |g Amsterdam [u.a.] |w (DE-627)ELV002357348 |
| 773 | 1 | 8 | |g volume:191 |g year:2014 |g day:15 |g month:01 |g pages:52-59 |g extent:8 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.resp.2013.10.010 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 951 | |a AR | ||
| 952 | |d 191 |j 2014 |b 15 |c 0115 |h 52-59 |g 8 | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
r s rs |
|---|---|
| matchkey_str |
sinojiaravikumarshaikhmoinkodgulerahulbh:2014----:rmnobt2gnsadniucrncnuepyilgclepneidcdy20gancnoea |
| hierarchy_sort_str |
2014 |
| publishDate |
2014 |
| allfields |
10.1016/j.resp.2013.10.010 doi GBVA2014007000004.pica (DE-627)ELV017396492 (ELSEVIER)S1569-9048(13)00347-9 DE-627 ger DE-627 rakwb eng 610 610 DE-600 330 VZ Sinojia, Ravikumar verfasserin aut Priming of beta-2 agonist and antimuscarinic induced physiological responses induced by 1200mg/day NAC in moderate to severe COPD patients: A pilot study 2014 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • We investigated effects of antioxidant on bronchodilator-response in COPD patients. • Antioxidant-therapy modulates antimuscarinic lung-hyperinflation responses. • No beta-2 agonist lung-physiology response was modulated by antioxidant-therapy. Ipratropium-bromide Elsevier Anti-oxidant Elsevier n-acetyl-cysteine Elsevier Priming Elsevier Salbutamol Elsevier Shaikh, Moin oth Kodgule, Rahul oth Bhosale, Satish oth Madas, Sapna oth Vaidya, Abhijit oth Salvi, Sundeep oth Brashier, Bill oth Enthalten in Elsevier Science Kumar, Abhishek ELSEVIER Usage of formal financial services in India: Demand barriers or supply constraints? 2018 Amsterdam [u.a.] (DE-627)ELV002357348 volume:191 year:2014 day:15 month:01 pages:52-59 extent:8 https://doi.org/10.1016/j.resp.2013.10.010 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U AR 191 2014 15 0115 52-59 8 045F 610 |
| spelling |
10.1016/j.resp.2013.10.010 doi GBVA2014007000004.pica (DE-627)ELV017396492 (ELSEVIER)S1569-9048(13)00347-9 DE-627 ger DE-627 rakwb eng 610 610 DE-600 330 VZ Sinojia, Ravikumar verfasserin aut Priming of beta-2 agonist and antimuscarinic induced physiological responses induced by 1200mg/day NAC in moderate to severe COPD patients: A pilot study 2014 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • We investigated effects of antioxidant on bronchodilator-response in COPD patients. • Antioxidant-therapy modulates antimuscarinic lung-hyperinflation responses. • No beta-2 agonist lung-physiology response was modulated by antioxidant-therapy. Ipratropium-bromide Elsevier Anti-oxidant Elsevier n-acetyl-cysteine Elsevier Priming Elsevier Salbutamol Elsevier Shaikh, Moin oth Kodgule, Rahul oth Bhosale, Satish oth Madas, Sapna oth Vaidya, Abhijit oth Salvi, Sundeep oth Brashier, Bill oth Enthalten in Elsevier Science Kumar, Abhishek ELSEVIER Usage of formal financial services in India: Demand barriers or supply constraints? 2018 Amsterdam [u.a.] (DE-627)ELV002357348 volume:191 year:2014 day:15 month:01 pages:52-59 extent:8 https://doi.org/10.1016/j.resp.2013.10.010 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U AR 191 2014 15 0115 52-59 8 045F 610 |
| allfields_unstemmed |
10.1016/j.resp.2013.10.010 doi GBVA2014007000004.pica (DE-627)ELV017396492 (ELSEVIER)S1569-9048(13)00347-9 DE-627 ger DE-627 rakwb eng 610 610 DE-600 330 VZ Sinojia, Ravikumar verfasserin aut Priming of beta-2 agonist and antimuscarinic induced physiological responses induced by 1200mg/day NAC in moderate to severe COPD patients: A pilot study 2014 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • We investigated effects of antioxidant on bronchodilator-response in COPD patients. • Antioxidant-therapy modulates antimuscarinic lung-hyperinflation responses. • No beta-2 agonist lung-physiology response was modulated by antioxidant-therapy. Ipratropium-bromide Elsevier Anti-oxidant Elsevier n-acetyl-cysteine Elsevier Priming Elsevier Salbutamol Elsevier Shaikh, Moin oth Kodgule, Rahul oth Bhosale, Satish oth Madas, Sapna oth Vaidya, Abhijit oth Salvi, Sundeep oth Brashier, Bill oth Enthalten in Elsevier Science Kumar, Abhishek ELSEVIER Usage of formal financial services in India: Demand barriers or supply constraints? 2018 Amsterdam [u.a.] (DE-627)ELV002357348 volume:191 year:2014 day:15 month:01 pages:52-59 extent:8 https://doi.org/10.1016/j.resp.2013.10.010 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U AR 191 2014 15 0115 52-59 8 045F 610 |
| allfieldsGer |
10.1016/j.resp.2013.10.010 doi GBVA2014007000004.pica (DE-627)ELV017396492 (ELSEVIER)S1569-9048(13)00347-9 DE-627 ger DE-627 rakwb eng 610 610 DE-600 330 VZ Sinojia, Ravikumar verfasserin aut Priming of beta-2 agonist and antimuscarinic induced physiological responses induced by 1200mg/day NAC in moderate to severe COPD patients: A pilot study 2014 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • We investigated effects of antioxidant on bronchodilator-response in COPD patients. • Antioxidant-therapy modulates antimuscarinic lung-hyperinflation responses. • No beta-2 agonist lung-physiology response was modulated by antioxidant-therapy. Ipratropium-bromide Elsevier Anti-oxidant Elsevier n-acetyl-cysteine Elsevier Priming Elsevier Salbutamol Elsevier Shaikh, Moin oth Kodgule, Rahul oth Bhosale, Satish oth Madas, Sapna oth Vaidya, Abhijit oth Salvi, Sundeep oth Brashier, Bill oth Enthalten in Elsevier Science Kumar, Abhishek ELSEVIER Usage of formal financial services in India: Demand barriers or supply constraints? 2018 Amsterdam [u.a.] (DE-627)ELV002357348 volume:191 year:2014 day:15 month:01 pages:52-59 extent:8 https://doi.org/10.1016/j.resp.2013.10.010 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U AR 191 2014 15 0115 52-59 8 045F 610 |
| allfieldsSound |
10.1016/j.resp.2013.10.010 doi GBVA2014007000004.pica (DE-627)ELV017396492 (ELSEVIER)S1569-9048(13)00347-9 DE-627 ger DE-627 rakwb eng 610 610 DE-600 330 VZ Sinojia, Ravikumar verfasserin aut Priming of beta-2 agonist and antimuscarinic induced physiological responses induced by 1200mg/day NAC in moderate to severe COPD patients: A pilot study 2014 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • We investigated effects of antioxidant on bronchodilator-response in COPD patients. • Antioxidant-therapy modulates antimuscarinic lung-hyperinflation responses. • No beta-2 agonist lung-physiology response was modulated by antioxidant-therapy. Ipratropium-bromide Elsevier Anti-oxidant Elsevier n-acetyl-cysteine Elsevier Priming Elsevier Salbutamol Elsevier Shaikh, Moin oth Kodgule, Rahul oth Bhosale, Satish oth Madas, Sapna oth Vaidya, Abhijit oth Salvi, Sundeep oth Brashier, Bill oth Enthalten in Elsevier Science Kumar, Abhishek ELSEVIER Usage of formal financial services in India: Demand barriers or supply constraints? 2018 Amsterdam [u.a.] (DE-627)ELV002357348 volume:191 year:2014 day:15 month:01 pages:52-59 extent:8 https://doi.org/10.1016/j.resp.2013.10.010 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U AR 191 2014 15 0115 52-59 8 045F 610 |
| language |
English |
| source |
Enthalten in Usage of formal financial services in India: Demand barriers or supply constraints? Amsterdam [u.a.] volume:191 year:2014 day:15 month:01 pages:52-59 extent:8 |
| sourceStr |
Enthalten in Usage of formal financial services in India: Demand barriers or supply constraints? Amsterdam [u.a.] volume:191 year:2014 day:15 month:01 pages:52-59 extent:8 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
Ipratropium-bromide Anti-oxidant n-acetyl-cysteine Priming Salbutamol |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Usage of formal financial services in India: Demand barriers or supply constraints? |
| authorswithroles_txt_mv |
Sinojia, Ravikumar @@aut@@ Shaikh, Moin @@oth@@ Kodgule, Rahul @@oth@@ Bhosale, Satish @@oth@@ Madas, Sapna @@oth@@ Vaidya, Abhijit @@oth@@ Salvi, Sundeep @@oth@@ Brashier, Bill @@oth@@ |
| publishDateDaySort_date |
2014-01-15T00:00:00Z |
| hierarchy_top_id |
ELV002357348 |
| dewey-sort |
3610 |
| id |
ELV017396492 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV017396492</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623134621.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180602s2014 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.resp.2013.10.010</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2014007000004.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV017396492</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1569-9048(13)00347-9</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">330</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Sinojia, Ravikumar</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Priming of beta-2 agonist and antimuscarinic induced physiological responses induced by 1200mg/day NAC in moderate to severe COPD patients: A pilot study</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2014</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">8</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• We investigated effects of antioxidant on bronchodilator-response in COPD patients. • Antioxidant-therapy modulates antimuscarinic lung-hyperinflation responses. • No beta-2 agonist lung-physiology response was modulated by antioxidant-therapy.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Ipratropium-bromide</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Anti-oxidant</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">n-acetyl-cysteine</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Priming</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Salbutamol</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Shaikh, Moin</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kodgule, Rahul</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bhosale, Satish</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Madas, Sapna</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Vaidya, Abhijit</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Salvi, Sundeep</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Brashier, Bill</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Kumar, Abhishek ELSEVIER</subfield><subfield code="t">Usage of formal financial services in India: Demand barriers or supply constraints?</subfield><subfield code="d">2018</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV002357348</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:191</subfield><subfield code="g">year:2014</subfield><subfield code="g">day:15</subfield><subfield code="g">month:01</subfield><subfield code="g">pages:52-59</subfield><subfield code="g">extent:8</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.resp.2013.10.010</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">191</subfield><subfield code="j">2014</subfield><subfield code="b">15</subfield><subfield code="c">0115</subfield><subfield code="h">52-59</subfield><subfield code="g">8</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Sinojia, Ravikumar |
| spellingShingle |
Sinojia, Ravikumar ddc 610 ddc 330 Elsevier Ipratropium-bromide Elsevier Anti-oxidant Elsevier n-acetyl-cysteine Elsevier Priming Elsevier Salbutamol Priming of beta-2 agonist and antimuscarinic induced physiological responses induced by 1200mg/day NAC in moderate to severe COPD patients: A pilot study |
| authorStr |
Sinojia, Ravikumar |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV002357348 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health 330 - Economics |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 330 VZ Priming of beta-2 agonist and antimuscarinic induced physiological responses induced by 1200mg/day NAC in moderate to severe COPD patients: A pilot study Ipratropium-bromide Elsevier Anti-oxidant Elsevier n-acetyl-cysteine Elsevier Priming Elsevier Salbutamol Elsevier |
| topic |
ddc 610 ddc 330 Elsevier Ipratropium-bromide Elsevier Anti-oxidant Elsevier n-acetyl-cysteine Elsevier Priming Elsevier Salbutamol |
| topic_unstemmed |
ddc 610 ddc 330 Elsevier Ipratropium-bromide Elsevier Anti-oxidant Elsevier n-acetyl-cysteine Elsevier Priming Elsevier Salbutamol |
| topic_browse |
ddc 610 ddc 330 Elsevier Ipratropium-bromide Elsevier Anti-oxidant Elsevier n-acetyl-cysteine Elsevier Priming Elsevier Salbutamol |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
m s ms r k rk s b sb s m sm a v av s s ss b b bb |
| hierarchy_parent_title |
Usage of formal financial services in India: Demand barriers or supply constraints? |
| hierarchy_parent_id |
ELV002357348 |
| dewey-tens |
610 - Medicine & health 330 - Economics |
| hierarchy_top_title |
Usage of formal financial services in India: Demand barriers or supply constraints? |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV002357348 |
| title |
Priming of beta-2 agonist and antimuscarinic induced physiological responses induced by 1200mg/day NAC in moderate to severe COPD patients: A pilot study |
| ctrlnum |
(DE-627)ELV017396492 (ELSEVIER)S1569-9048(13)00347-9 |
| title_full |
Priming of beta-2 agonist and antimuscarinic induced physiological responses induced by 1200mg/day NAC in moderate to severe COPD patients: A pilot study |
| author_sort |
Sinojia, Ravikumar |
| journal |
Usage of formal financial services in India: Demand barriers or supply constraints? |
| journalStr |
Usage of formal financial services in India: Demand barriers or supply constraints? |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology 300 - Social sciences |
| recordtype |
marc |
| publishDateSort |
2014 |
| contenttype_str_mv |
zzz |
| container_start_page |
52 |
| author_browse |
Sinojia, Ravikumar |
| container_volume |
191 |
| physical |
8 |
| class |
610 610 DE-600 330 VZ |
| format_se |
Elektronische Aufsätze |
| author-letter |
Sinojia, Ravikumar |
| doi_str_mv |
10.1016/j.resp.2013.10.010 |
| dewey-full |
610 330 |
| title_sort |
priming of beta-2 agonist and antimuscarinic induced physiological responses induced by 1200mg/day nac in moderate to severe copd patients: a pilot study |
| title_auth |
Priming of beta-2 agonist and antimuscarinic induced physiological responses induced by 1200mg/day NAC in moderate to severe COPD patients: A pilot study |
| abstract |
• We investigated effects of antioxidant on bronchodilator-response in COPD patients. • Antioxidant-therapy modulates antimuscarinic lung-hyperinflation responses. • No beta-2 agonist lung-physiology response was modulated by antioxidant-therapy. |
| abstractGer |
• We investigated effects of antioxidant on bronchodilator-response in COPD patients. • Antioxidant-therapy modulates antimuscarinic lung-hyperinflation responses. • No beta-2 agonist lung-physiology response was modulated by antioxidant-therapy. |
| abstract_unstemmed |
• We investigated effects of antioxidant on bronchodilator-response in COPD patients. • Antioxidant-therapy modulates antimuscarinic lung-hyperinflation responses. • No beta-2 agonist lung-physiology response was modulated by antioxidant-therapy. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U |
| title_short |
Priming of beta-2 agonist and antimuscarinic induced physiological responses induced by 1200mg/day NAC in moderate to severe COPD patients: A pilot study |
| url |
https://doi.org/10.1016/j.resp.2013.10.010 |
| remote_bool |
true |
| author2 |
Shaikh, Moin Kodgule, Rahul Bhosale, Satish Madas, Sapna Vaidya, Abhijit Salvi, Sundeep Brashier, Bill |
| author2Str |
Shaikh, Moin Kodgule, Rahul Bhosale, Satish Madas, Sapna Vaidya, Abhijit Salvi, Sundeep Brashier, Bill |
| ppnlink |
ELV002357348 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth |
| doi_str |
10.1016/j.resp.2013.10.010 |
| up_date |
2024-07-06T21:52:02.652Z |
| _version_ |
1803868147708592128 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV017396492</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623134621.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180602s2014 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.resp.2013.10.010</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2014007000004.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV017396492</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1569-9048(13)00347-9</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">330</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Sinojia, Ravikumar</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Priming of beta-2 agonist and antimuscarinic induced physiological responses induced by 1200mg/day NAC in moderate to severe COPD patients: A pilot study</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2014</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">8</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• We investigated effects of antioxidant on bronchodilator-response in COPD patients. • Antioxidant-therapy modulates antimuscarinic lung-hyperinflation responses. • No beta-2 agonist lung-physiology response was modulated by antioxidant-therapy.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Ipratropium-bromide</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Anti-oxidant</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">n-acetyl-cysteine</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Priming</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Salbutamol</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Shaikh, Moin</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kodgule, Rahul</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bhosale, Satish</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Madas, Sapna</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Vaidya, Abhijit</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Salvi, Sundeep</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Brashier, Bill</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Kumar, Abhishek ELSEVIER</subfield><subfield code="t">Usage of formal financial services in India: Demand barriers or supply constraints?</subfield><subfield code="d">2018</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV002357348</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:191</subfield><subfield code="g">year:2014</subfield><subfield code="g">day:15</subfield><subfield code="g">month:01</subfield><subfield code="g">pages:52-59</subfield><subfield code="g">extent:8</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.resp.2013.10.010</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">191</subfield><subfield code="j">2014</subfield><subfield code="b">15</subfield><subfield code="c">0115</subfield><subfield code="h">52-59</subfield><subfield code="g">8</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.3989916 |